Nazila Bahmaie | Immunology and Microbiology | Best Researcher Award

Posted on by ScienceFather

Dr. Nazila Bahmaie | Immunology and Microbiology | Best Researcher Award

clinical research assistant at Ankara Yildirim Beyazit University, Turkey

Nazila Bahmaie is a dedicated researcher and PhD candidate specializing in Cancer Biology. Born in Ahvaz, Iran, on December 21, 1990, she has pursued an academic and research career across multiple countries, including Iran, Cyprus, and Turkey. Currently enrolled at Ankara Yildirim Beyazit University in Turkey, Nazila is focused on advancing her expertise in cancer biology. Her international academic experience has allowed her to engage with diverse research methodologies, enhancing her scientific adaptability. With a deep commitment to biomedical research, she aims to contribute to groundbreaking discoveries in cancer treatment and immunology. Nazila’s extensive background in medical sciences reflects her passion for understanding complex biological processes and her dedication to improving global healthcare outcomes.

Professional Profile

Education

Nazila Bahmaie has an impressive academic background, with degrees in cellular and molecular biology, medical microbiology, and immunology. She completed her BSc in Cellular and Molecular Biology, majoring in Microbiology, at Maragheh University in Iran, followed by an MSc in Medical Microbiology and Immunology at Zanjan University of Medical Sciences, where she graduated with distinction. Continuing her academic journey, she pursued a PhD in Immunology and Allergy at Near East University in Cyprus before transferring to her current PhD program in Cancer Biology at Ankara Yildirim Beyazit University in Turkey. Her educational trajectory demonstrates a consistent focus on biology and medical sciences, with an emphasis on translational research that bridges basic science and clinical applications.

Professional Experience

Nazila Bahmaie’s professional journey includes significant research roles in cancer biology, immunology, and medical microbiology. As a PhD candidate at Ankara Yildirim Beyazit University, she conducts cancer research under the guidance of prominent scientists, focusing on cancer biology and immunological mechanisms. Before this, she contributed to the field of immunology during her PhD fellowship at Near East University, where she explored pediatric immunology and allergy. Nazila has also worked in medical microbiology, conducting essential research during her MSc studies at Zanjan University of Medical Sciences. Her professional experiences have equipped her with diverse research skills, including cellular and molecular techniques, and a deep understanding of immune responses in diseases.

Research Interests

Nazila Bahmaie’s research interests are focused on the intersection of cancer biology and immunology, particularly in understanding the molecular mechanisms that drive cancer progression and how the immune system can be leveraged to treat cancers. She is deeply involved in studying the immune responses in cancer patients and exploring innovative immunotherapy approaches that could lead to more effective treatments. Her background in microbiology also informs her interest in how microbial infections can influence immune regulation and cancer development. Nazila aims to contribute to the development of targeted therapies that enhance the body’s immune response against tumors, making her research both translational and clinically relevant.

Awards and Honors

Nazila Bahmaie has consistently excelled throughout her academic career, earning high honors and recognition for her academic performance. She graduated with distinction during her MSc in Medical Microbiology and Immunology, earning an A++ for her academic achievements at Zanjan University of Medical Sciences. In addition, she successfully secured a PhD fellowship in Immunology and Allergy at Near East University, showcasing her dedication and merit in the field. While specific awards and honors related to her current PhD work are not detailed, her academic trajectory and continuous involvement in research highlight her potential for future recognition in the scientific community, particularly in cancer biology and immunology.

Conclusion

Nazila Bahmaie has a solid academic foundation and promising potential, particularly in the fields of cancer biology and immunology. However, to be a strong contender for the Best Researcher Award, she would benefit from expanding her publication portfolio, demonstrating a clear impact of her research, and engaging in leadership roles. If she addresses these areas, she could emerge as a notable candidate in future award cycles.

Publication top noted

  • 📄 47D11 Antibody-Engineered Exosomes for Targeted Delivery of Remdesivir in Patients with COVID-19: Dream or Principle? (A Critical Editorial Study)
    • Authors: Daneshi, N., Esmaeilzadeh, A., Bahmaie, N.
    • Journal: Eurasian Journal of Medicine
    • Year: 2022
    • Citations: 1
  • 📄 Cell-Free Treatments: A New Generation of Targeted Therapies for Treatment of Ischemic Heart Diseases
    • Authors: Daneshi, N., Bahmaie, N., Esmaeilzadeh, A.
    • Journal: Cell Journal
    • Year: 2022
    • Citations: 3
  • 📄 Immunobiological Properties and Clinical Applications of Interleukin-38 for Immune-Mediated Disorders: A Systematic Review Study
    • Authors: Esmaeilzadeh, A., Bahmaie, N., Nouri, E., Hajkazemi, M.J., Rafie, M.Z.
    • Journal: International Journal of Molecular Sciences
    • Year: 2021
    • Citations: 8
  • 📄 The Clinical Efficacy of Rituximab Administration in Autoimmunity Disorders, Primary Immunodeficiency Diseases and Malignancies
    • Authors: Zian, Z., Berry, S.P.D.-G., Bahmaie, N., Khan, H., Azizi, G.
    • Journal: International Immunopharmacology
    • Year: 2021
    • Citations: 5
  • 📄 Clinical Applications of Interleukin-37: A Key Player in the Immunopathogenesis of Immune Disorders
    • Authors: Khosh, E., Bahmaie, N., Elahi, R., Esmaeilzadeh, A.
    • Journal: Iranian Journal of Allergy, Asthma and Immunology
    • Year: 2020
    • Citations: 2

 

Francisco Boix Giner | Immunology and Microbiology | Best Researcher Award

Posted on by ScienceFather

Dr. Francisco Boix Giner | Immunology and Microbiology | Best Researcher Award

Clinical Immunologist, Blood Transfusion Center of the Valencian Community, Spain

Francisco José Boix Giner is a distinguished immunologist with a strong academic and professional background. Currently working at the Centro de Transfusión de la Comunidad Valenciana, he has a notable career in both clinical and research settings. Boix Giner’s expertise spans genomic characterization, immunogenetics, and biomarker validation, evidenced by his leadership in multiple research projects, including studies on leukemia, COVID-19, and organ transplantation. He earned his Ph.D. from the University of Murcia with a thesis on immunosuppressive treatment biomarkers. His professional experience includes roles at prestigious institutions such as the National Health Service Blood and Transplant and Anthony Nolan in the UK. With an h-index of 15 and substantial contributions to various research projects, Boix Giner’s work is highly regarded in the field of immunology. His research achievements reflect a deep commitment to advancing knowledge in immunogenetics and personalized medicine.

Profile

Education

Francisco José Boix Giner holds a comprehensive academic background in biomedical sciences. He earned his undergraduate degree in Biological Sciences with a specialization in Biomedicine from the University of Alicante in Spain, graduating with honors in September 2006. He further pursued advanced studies by completing a Master’s degree in Biomedical Technology and Research at the University of Murcia in September 2010, where he achieved an outstanding grade. Francisco then obtained his Ph.D. from the University of Murcia in June 2017, with a thesis focused on validating biomarkers for transplant patients undergoing immunosuppressive treatment. His doctoral work was conducted under the guidance of Manuel Muro Amador and Rocío Álvarez López, and it was awarded the highest distinction of “Sobresaliente Cum Laude.” This rigorous educational foundation has significantly contributed to his expertise and research in immunology and biomolecular sciences.

Professional Experience

Francisco José Boix Giner has accumulated extensive experience in immunology across several prestigious institutions. He currently serves as a Specialist in Immunology at the Centro de Transfusión de la Comunidad Valenciana, where he has been employed since November 2021. Previously, Boix held similar roles at the Hospital Universitario de Salamanca from June 2018 to November 2021, the National Health Service Blood and Transplant, and the Anthony Nolan Foundation in the UK, from 2013 to 2018. His career began at the Hospital Universitario Virgen de La Arrixaca, where he completed his residency in immunology. Boix’s work has involved leading and contributing to significant research projects, including genomic characterization of leukemia and studies on COVID-19 immunogenetics. His professional journey reflects a robust expertise in both clinical and research settings within the field of immunology.

Research Interest

Francisco José Boix Giner’s research interests center around immunology, with a particular focus on the genetic and molecular mechanisms underlying immune responses and transplant outcomes. His work includes characterizing genetic variations associated with immune system functions, such as the role of HLA and KIR genes in disease susceptibility and treatment responses. He has been involved in projects studying the impact of genetic markers on the resistance and relapse of leukemia, as well as the immunogenetic factors influencing COVID-19 prognosis. His research also extends to exploring biomarkers for assessing individual responses to immunosuppressive treatments in organ transplant patients. Boix Giner’s contributions aim to enhance the understanding of immune system interactions, improve diagnostic and therapeutic strategies, and advance personalized medicine in immunology and transplant science.

Research Skills

Francisco José Boix Giner possesses extensive research skills in the field of immunology and biomedicine. His expertise spans across various critical areas, including the characterization of genomic mechanisms in high-risk leukemia, the impact of HLA system on SARS-CoV-2 infections, and the identification of immune genetic variations in COVID-19 patients. Boix Giner has a proven track record in coordinating and leading significant research projects, such as those focused on biomarkers for preeclampsia and uterine growth restriction, as well as haplotypic characterization in leukemia patients. His proficiency in advanced techniques, including next-generation sequencing (NGS) and single-cell analysis, is complemented by his ability to secure and manage substantial research funding. His role in high-impact projects and collaborations with esteemed institutions highlights his skill in translating complex scientific data into actionable insights, furthering advancements in immunological research and patient care.

Award and Recognition

Francisco José Boix Giner, an esteemed immunologist, has garnered notable recognition in his field through a series of distinguished awards and accolades. He has been acknowledged for his significant contributions to the field of immunology, particularly in genomics and biomarker research. Boix Giner’s exceptional work has been recognized with multiple awards, including those for his innovative research on immune responses and transplantation. His research on the characterization of genomic mechanisms in leukemia and the validation of biomarkers in transplantation has earned him commendations from various institutions. In addition, he has received accolades for his leadership in high-impact research projects and his contributions to advancing understanding in immunogenetics and biomedicine. Boix Giner’s accolades underscore his commitment to scientific excellence and his influential role in the advancement of immunological research.

Conclusion

Francisco José Boix Giner is a well-qualified candidate for the Research for Best Researcher Award due to his extensive experience, significant contributions to immunology research, and strong academic background. To further strengthen his candidacy, focusing on increasing high-impact publications, expanding his research scope, and enhancing public engagement could be beneficial. Overall, his achievements and expertise make him a compelling candidate for the award.

Publication Top Notes

  1. Killer-cell immunoglobulin-like receptor polymorphism is associated with COVID-19 outcome: Results of a pilot observational study
    • Authors: Niño-Ramírez, J.E., Alcoceba, M., Gutiérrez-Zufiaurre, M.N., García-Sanz, R., Boix, F.
    • Year: 2024
    • Journal: HLA
  2. CD8+CD69+ and CD8+CD95+ Mediate Early Post-Transplant Acute Tubular Injury in Kidney Recipients
    • Authors: Boix, F., Jimenez-Coll, V., Legaz, I., Llorente, S., Muro, M.
    • Year: 2023
    • Journal: Frontiers in Bioscience – Landmark
    • Citations: 1
  3. Monitoring of Serological, Cellular and Genomic Biomarkers in Transplantation, Computational Prediction Models and Role of Cell-Free DNA in Transplant Outcome
    • Authors: Jimenez-Coll, V., Llorente, S., Boix, F., Legaz, I., Muro, M.
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
    • Citations: 5
  4. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy
    • Authors: Bailén, R., Alenda, R., Herruzo-Delgado, B., Anguita, J., Kwon, M.
    • Year: 2023
    • Journal: Frontiers in Immunology
    • Citations: 4
  5. Identification of the novel HLA-A*23:01:01:27 allele in an acute myeloid patient and related donor
    • Authors: Bastos, M., Alcoceba, M., Chillón, M.C., García-Sanz, R., Boix, F.
    • Year: 2022
    • Journal: HLA
    • Citations: 2
  6. The age again in the eye of the COVID-19 storm: evidence-based decision making
    • Authors: Martín, M.C., Jurado, A., Abad-Molina, C., Ocaña, E., Molina, J.
    • Year: 2021
    • Journal: Immunity and Ageing
    • Citations: 7
  7. The novel HLA-DQB1*06:03:27 allele characterised by sequence-based typing in a European bone marrow donor
    • Authors: Boix, F., Chillón, M.C., García-Sánchez, S., Alcoceba, M., Marín-Rubio, L.A.
    • Year: 2021
    • Journal: HLA
    • Citations: 2
  8. Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome
    • Authors: El Band, J.E.K., Llorente, S., Martinez-Garcia, P., Legaz, I., Muro, M.
    • Year: 2021
    • Journal: Current Protein and Peptide Science
    • Citations: 2
  9. Allele and haplotype frequencies of HLA-A, -B, -C, -DRB1, -DQB1 and -DQA1 in Castile and Leon region from North West of Spain
    • Authors: Boix, F., Marín-Rubio, L.A., Alcoceba, M., González, M., García-Sanz, R.
    • Year: 2021
    • Journal: Human Immunology
    • Citations: 1
  10. Microrna expression changes in kidney transplant: Diagnostic efficacy of mir-150-5p as potential rejection biomarker, pilot study
    • Authors: Alfaro, R., Legaz, I., Jimenez-Coll, V., Llorente, S., Muro, M.
    • Year: 2021
    • Journal: Journal of Clinical Medicine
    • Citations: 14

 

 

Fahimeh Alizadeh | Immunology and Microbiology | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Fahimeh Alizadeh | Immunology and Microbiology | Best Researcher Award

Supervisor of Islamic Azad University, Iran.

Dr. Fahimeh Alizadeh is an accomplished researcher and educator in the field of microbial biotechnology, currently serving as an Associate Professor at the Department of Biology, Islamic Azad University, Gachsaran, Iran. With over two decades of experience in academia, she has previously held roles at the Yasooj Branch of Islamic Azad University, including positions as Head of the Department of Biology and Paramedical Sciences. Dr. Alizadeh’s research expertise encompasses microbial interactions, nanoparticle applications, and antifungal and antibacterial agents. Her significant contributions include research on the molecular mechanisms of Candida species, nanoparticle-based therapies, and biofilm formation. She has secured notable research grants and published extensively in high-impact journals. Dr. Alizadeh holds a Ph.D. from the University of Putra Malaysia and a Post-Doctoral fellowship from the same institution. Her extensive publication record and leadership in scientific research underscore her prominent role in her field.

Profile
Education

Fahimeh Alizadeh holds a robust academic background in microbiology and microbial biotechnology. She completed her Bachelor’s and Master’s degrees in Biology-Microbiology at Islamic Azad University, Iran, where she laid the foundation for her specialization. She further advanced her expertise by earning a Ph.D. in Microbial Biotechnology from the University of Putra Malaysia, Malaysia, where she delved into advanced research techniques and microbial interactions. Dr. Alizadeh continued her scholarly journey with a post-doctoral fellowship at the same institution, focusing on cutting-edge microbial biotechnology. Her educational trajectory reflects a strong commitment to understanding microbial systems and advancing biotechnological applications, equipping her with comprehensive knowledge and research capabilities in her field.

Professional Experience

Dr. Fahimeh Alizadeh has an extensive academic and research career, currently serving as an Associate Professor in the Department of Biology at Gachsaran Branch, Islamic Azad University, Iran since 2023. Prior to this role, she was an Assistant Professor at Yasooj Branch, Islamic Azad University from 2000 to 2023, where she also held leadership positions as Head of the Department of Biology and Head of the Department of Paramedical Sciences at different intervals. Her teaching expertise spans across various subjects, including Biology, Medical Biochemistry, Immunology, and Microbiology. Dr. Alizadeh’s research experience is highlighted by her involvement in several significant projects and grants, including studies on microbial interactions, nanoparticles, and antifungal activities. Her contributions to the field are reflected in her numerous journal publications and research grants, underscoring her commitment to advancing scientific knowledge in microbial biotechnology and related disciplines.

Research Interest

Fahimeh Alizadeh’s research interests encompass a wide array of topics in microbial biotechnology and medical microbiology. Her work primarily focuses on exploring molecular mechanisms underlying microbial interactions, particularly involving fungal pathogens such as Candida albicans. She is deeply involved in studying the inhibitory effects of natural compounds and nanoparticles on pathogenic microorganisms and their biofilms. Her research aims to elucidate the molecular targets and mechanisms of antimicrobial agents, including thymol- and carvacrol-loaded nanoparticles, in combating drug-resistant strains and cancer cells. Additionally, Alizadeh investigates the role of transcription factors and signaling molecules in plant-pathogen interactions, emphasizing the defense responses in oil palm against fungal pathogens. Her extensive studies on the molecular and phenotypic characterization of microbial resistance and biofilm formation contribute significantly to the development of novel therapeutic strategies and antimicrobial agents.

Research Skills

Dr. Fahimeh Alizadeh demonstrates exceptional research skills in the field of microbiology and microbial biotechnology. Her expertise encompasses a broad range of techniques and methodologies, including the isolation and characterization of transcription factors, the development of nanoparticles for therapeutic applications, and the study of antifungal and antibacterial properties of natural compounds. Dr. Alizadeh excels in molecular profiling and transcriptomic analysis, employing massive parallel sequencing to investigate gene expression during pathogen interactions. Her research frequently involves complex in vitro and in vivo studies, such as evaluating the inhibitory effects of various compounds on pathogenic microorganisms and cancer cell lines. Her ability to synthesize and analyze data from diverse experimental approaches highlights her proficiency in translating fundamental research into practical applications. This comprehensive skill set underscores her significant contributions to advancing knowledge in microbial biotechnology and therapeutic development.

Awards and Recognition

Dr. Fahimeh Alizadeh has garnered notable recognition for her impactful contributions to microbial biotechnology and her extensive research in the field. She has been acknowledged for her groundbreaking work on the molecular mechanisms of antifungal agents and nanoparticles in combating resistant pathogens. Her research projects, such as the study on thymol- and carvacrol-loaded nanoparticles and Candida species, have significantly advanced the understanding of antifungal resistance mechanisms. Dr. Alizadeh’s publications in prominent journals, including Pharmaceutical Sciences and Applied Biochemistry and Biotechnology, highlight her expertise and commitment to advancing medical and environmental microbiology. Her leadership roles as Head of the Department of Biology at Yasooj Branch and her active involvement in international research projects further demonstrate her excellence in academia. These achievements underscore her significant contributions to science and her esteemed position in the research community.

Conclusion

Fahimeh Alizadeh is a highly qualified candidate for the Research for Best Researcher Award, with extensive experience in academia, significant research contributions, and a strong publication record. Her leadership roles and research projects highlight her expertise and commitment to advancing microbial biotechnology.

Publications Top Notes

  • Anti-cancer activity of secreted aspartyl proteinase protein from Candida tropicalis on human cervical cancer HeLa cells
    • Authors: E.P. Kokhdan, P. Khodavandi, M.H. Ataeyan, A. Khodavandi, A. Zaheri
    • Year: 2024
  • Possible Molecular Targeting of Biofilm-Associated Genes by Nano-Ag in Candida albicans
    • Authors: M.B. Esfahani, A. Khodavandi, F. Alizadeh, N. Bahador
    • Year: 2024
  • Possibility of intrauterine transmission from mother to fetus/newborn: Systematic review and meta-analysis of diagnostic methods to detect SARS-CoV-2 infection
    • Authors: P. Khodavandi, A. Khodavandi, F. Alizadeh, L. Gholizadeh
    • Year: 2024
    • Citations: 1
  • Hyphae-specific genes: Possible molecular targets for magnetic iron oxide nanoparticles alone and combined with visible light in Candida albicans
    • Authors: P. Khodavandi, A. Hosseini, A. Khodavandi, A. Azizi, M. Gerami
    • Year: 2023
    • Citations: 1
  • Antibacterial and Anti-Biofilm Activities of Microbial Synthesized Silver and Magnetic Iron Oxide Nanoparticles Against Pseudomonas aeruginosa
    • Authors: M.B. Esfahani, A. Khodavandi, F. Alizadeh, N. Bahador
    • Year: 2023
    • Citations: 3
  • Biofilm-associated genes as potential molecular targets of nano-Fe3O4 in Candida albicans
    • Authors: M. Baghiat Esfahani, A. Khodavandi, F. Alizadeh, N. Bahador
    • Year: 2023
    • Citations: 1
  • Synergistic interaction of fluconazole/ sodium bicarbonate on the inhibition of Candida glabrata phospholipase gene
    • Authors: S.M.K. Hosseini, F. Alizadeh, S. Nouripour-Sisakht, A. Khodavandi
    • Year: 2022
  • Resistance profiling of metallo-betalactamase genes in clinical isolates of Enterobacteriaceae: Emergence of multidrug resistance
    • Authors: H. Alizadeh, A. Khodavandi, F. Alizadeh, N. Bahador
    • Year: 2021
    • Citations: 2
  • Antifungal activity of menthol alone and in combination on growth inhibition and biofilm formation of Candida albicans
    • Authors: N. Norouzi, F. Alizadeh, A. Khodavandi, M. Jahangiri
    • Year: 2021
    • Citations: 15
  • Association between dietary intake and risk of ovarian cancer: a systematic review and meta-analysis
    • Authors: A. Khodavandi, F. Alizadeh, A.F.A. Razis
    • Year: 2021
    • Citations: 28